Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1001
PUT
Flutter Entertainment
FLUT
$13B
| $31.5M | 0.01% |
146,600
+126,600
| +633% | +$28.5M |
2025 Q3
1 quarter
|
|
1002
PUT
Ross Stores
ROST
$73B
| $31.5M | 0.01% |
+175,000
| New | +$29.2M |
2025 Q4
0 quarters
|
|
1003
Builders FirstSource
BLDR
$6.05B
| $31.4M | 0.01% |
305,110
-57,899
| -16% | -$6.51M |
2013 Q2
50 quarters
|
|
1004
CAVA Group
CAVA
$6.36B
| $31.4M | 0.01% |
534,517
+237,323
| +80% | +$13.2M |
2023 Q2
10 quarters
|
|
1005
PUT
Rivian
RIVN
$20.7B
| $31.4M | 0.01% |
1,591,000
-2,009,900
| -56% | -$31.9M |
2024 Q3
5 quarters
|
|
1006
First Citizens BancShares
FCNCA
$23.4B
| $31.1M | 0.01% |
14,491
-12,514
| -46% | -$23.6M |
2016 Q1
39 quarters
|
|
1007
TriNet
TNET
$2.9B
| $31M | 0.01% |
524,650
+62,704
| +14% | +$3.73M |
2014 Q2
46 quarters
|
|
1008
Hims & Hers Health
HIMS
$6.77B
| $31M | 0.01% |
953,471
+294,500
| +45% | +$12.6M |
2022 Q1
15 quarters
|
|
1009
Enphase Energy
ENPH
$4.42B
| $30.9M | 0.01% |
963,515
-37,460
| -4% | -$1.21M |
2017 Q2
34 quarters
|
|
1010
Zions Bancorporation
ZION
$9.22B
| $30.8M | 0.01% |
526,674
-216,704
| -29% | -$11.8M |
2013 Q2
50 quarters
|
|
1011
PUT
Ford
F
$48.2B
| $30.8M | 0.01% |
2,347,600
+281,300
| +14% | +$3.63M |
2024 Q3
5 quarters
|
|
|
1012
CALL
Gilead Sciences
GILD
$179B
| $30.7M | 0.01% |
250,500
| – | – |
2022 Q4
12 quarters
|
|
1013
Progress Software
PRGS
$1.51B
| $30.7M | 0.01% |
715,691
+200,692
| +39% | +$8.75M |
2016 Q1
39 quarters
|
|
1014
Sunoco
SUN
$14.1B
| $30.5M | 0.01% |
582,140
-11,830
| -2% | -$625K |
2014 Q2
46 quarters
|
|
1015
CALL
Airbnb
ABNB
$95.8B
| $30.5M | 0.01% |
224,700
+174,500
| +348% | +$21.7M |
2025 Q3
1 quarter
|
|
1016
Taysha Gene Therapies
TSHA
$1.51B
| $30.5M | 0.01% |
5,539,001
+390,889
| +8% | +$1.9M |
2024 Q2
6 quarters
|
|
|
BA.PRA
1017
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
$6.9B
| $30.5M | 0.01% |
441,084
-276,077
| -38% | -$18.5M |
2024 Q4
4 quarters
|
|
1018
JD.com
JD
$34.8B
| $30.4M | 0.01% |
1,060,572
+128,986
| +14% | +$4.03M |
2014 Q3
45 quarters
|
|
1019
PUT
State Street SPDR S&P Bank ETF
KBE
$1.49B
| $30.3M | 0.01% |
+500,000
| New | +$29.5M |
2025 Q4
0 quarters
|
|
1020
CALL
Yum China
YUMC
$13.5B
| $30.3M | 0.01% |
635,000
-30,000
| -5% | -$1.37M |
2024 Q3
5 quarters
|
|
1021
CALL
Lamb Weston
LW
$5.99B
| $30.2M | 0.01% |
+721,900
| New | +$42.5M |
2025 Q4
0 quarters
|
|
1022
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$25.9B
| $30.2M | 0.01% |
+50,000
| New | +$29.9M |
2025 Q4
0 quarters
|
|
1023
Clorox
CLX
$9.72B
| $30.1M | 0.01% |
298,718
-96,720
| -24% | -$10.5M |
2013 Q2
50 quarters
|
|
1024
Progyny
PGNY
$1.94B
| $30.1M | 0.01% |
1,172,436
-403,034
| -26% | -$9.27M |
2022 Q1
15 quarters
|
|
1025
Kratos Defense & Security Solutions
KTOS
$8.09B
| $30.1M | 0.01% |
396,129
-17,385
| -4% | -$1.42M |
2016 Q3
37 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.